SCHEMBL7478049

SCHEMBL7478049

CN(C)CCN(C)c1nc2c([N+](=O)[O-])cccc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.48
PKN2 Q16513 1/20 0.48
ADORA3 P0DMS8 1/20 0.44
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
ALDH1A1 P00352 4/20 0.40
PDE10A Q9Y233 1/20 0.38
KCNMA1 Q12791 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
MAOA P21397 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADORA2A P29274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475814 0.89 PKN1 (0.47) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7966716 0.84 PKN1 (0.55) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7482602 0.81 PKN1 (0.49) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7486947 0.79 PKN1 (0.52) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7016736 0.78 PKN1 (0.46) PKN1PKN2ADORA3MGAMGAA
SCHEMBL7963781 0.77 MEN1 (0.43) PKN2GAAALDH1A1KCNMA1NOS1
SCHEMBL7964827 0.76 CHRM2 (0.52) PKN1PKN2ADORA3MGAMGAA
SCHEMBL1013588 0.74 PKN1 (0.60) PKN1PKN2ADORA3MGAMGAA
SCHEMBL6332531 0.73 PKN1 (0.61) PKN1PKN2ADORA3MGAMGAA
SCHEMBL8598342 0.72 GAA (0.56) PKN1PKN2ADORA3MGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed